Manufacturing news briefs – stories you might have missed

Imagion completes move to new R&D, production facility Breast cancer detection company Imagion Biosystems has moved into new facilities housing its offices, R&D activities and nanoparticle synthesis operation. The facility provides additional manufacturing capacity for its specialised MagSense nanoparticles. These are coated with tumour targeting antibodies which are used to test for HER2 positive breast…

Details

MMI grants pass review, were politicised – Husic

The industry minister Ed Husic has announced that the government’s examination of Modern Manufacturing Initiative grants has concluded and that announced grants will now be actioned. Husic said that the review showed the 68 grants were all supported by an independent Assessment Committee and the processes adhered to the publicly available Grant Opportunity Guidelines. He…

Details

Most people self medicating with illicit cannabis

While manufacturers are investing to increase legal production of medicinal cannabis products, most Australians are still self-medicating with illicit cannabis, according to a study by the University of Sydney’s Lambert Initiative. The third Cannabis as Medicine Survey (CAMS20) did find, however that numbers accessing prescription products have risen dramatically. The study of 1,600 people using…

Details